arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Elanco Animal Health Inc

ELAN
$22.10 ▼ -2.09 (-8.66%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
38 Visible periods
27 Metrics
Peer-ranked Benchmarks
Price Chart
36
Health
Weak
Bearish
auto_awesome

Analytical Summary

Elanco Animal Health Inc faces fundamental challenges with weakness in Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $11.0B
Dividend Yield
Revenue Growth 14.9%
Op. Margin
ROIC
FCF / Share $-0.08
Trailing P/E 200.9x
Price / Book 1.7x
FCF Yield
Debt / Equity 0.57
info Valuation on last close. End-of-day price, Aug 7, 2026.

38-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.37B
↑ +14.9%
Net Income Profit after all expenses
$57.00M
↓ -14.9%
FCF / Share Free cash flow per share
$-0.08
↑ +45.2%
Long-Term Debt Long-term obligations
$3.74B
↓ -0.7%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability
34
Returns
40
Financial Health
46
Cash Quality
9

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 38 quarters